Accelerating precision medicine in metastatic prostate cancer

Despite advances in prostate cancer screening and treatment, available therapy options, particularly in later stages of the disease, remain limited and the treatment-resistant setting represents a serious unmet medical need. Moreover, disease heterogeneity and disparities in patient access to medica...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Cancer
Main Authors: Mateo, Joaquin, McKay, Rana, Abida, Wassim, Aggarwal, Rahul, Alumkal, Joshi, Alva, Ajjai, Feng, Felix, Gao, Xin, Graff, Julie, Hussain, Maha, Karzai, Fatima, Montgomery, Bruce, Oh, William, Patel, Vaibhav, Rathkopf, Dana, Rettig, Matthew, Schultz, Nikolaus, Smith, Matthew, Solit, David, Sternberg, Cora, Van Allen, Eliezer, VanderWeele, David, Vinson, Jake, Soule, Howard R., Chinnaiyan, Arul, Small, Eric, Simons, Jonathan W., Dahut, William, Miyahira, Andrea K., Beltran, Himisha
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8274325/
https://ncbi.nlm.nih.gov/pubmed/34258585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s43018-020-00141-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados